Related Articles
KD025, an anti‑adipocyte differentiation drug, enhances the efficacy of conventional chemotherapeutic drugs in ABCG2‑overexpressing leukemia cells
The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance
The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma
Masitinib antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance
Dexamethasone reduces side population fraction through downregulation of ABCG2 transporter in MCF-7 breast cancer cells